Vizamyl Solution
Product Images NDC 17156-067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vizamyl (NDC 17156-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc. (medi-physics, Inc. Dba Ge Healthcare), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Vizamyl 01)

FDA Label Image

Figure 2 (Vizamyl 02)

FDA Label Image

Figure 3 (Vizamyl 03)

Figure 3 (Vizamyl 03)
This is a very short text that does not give enough information to generate a useful description. It appears to be referencing something called "pc" and two types of scans, positive and negative, but without further context or information it is not possible to provide a meaningful interpretation.*
FDA Label Image

Chemical Structure (Vizamyl 04)

FDA Label Image

Principal Display Panel (Shield Label)

Principal Display Panel (Shield Label)
NDC 17156-067-30 is a multiple dose vial of Vizamyl (Flutemetamol F 18 Injection). It contains 150 MBq (4.05 mCi) of flutemetamol, 7% ethanol, 0.9% sodium chloride, and 0.5% polysorbate 80 in 0.014 M phosphate buffer. The injection is sterile, non-pyrogenic, and intended for intravenous use only. The solution can be stored between 2°C to 30°C (35.6°F to 86°F). The product is manufactured by Cardinal Health 414, LLC for GE Healthcare, Medi-Physics Inc. in the U.S.A. The batch number, date, and vial number are also mentioned. The expiry date is not given.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.